UPDATE: Gemphire Adjustment To Gemcabene Deal With Pfizer Includes Extension Of Date For Deadline For First Commercial Sale Of Gemcabene: Pfizer Has Right To Terminate License If First Sale Has Not Occurred By Apr. 2024, Up From Apr. 2021 Previously
Benzinga Newsdesk